Skip to main content
. 2012 Jul 3;104(13):990–1004. doi: 10.1093/jnci/djs256

Table 5.

. Effects of intervention compared with control conditions and subgroup meta-analyses

Study or subgroup Hedges’ g* (95% CI) P
Effect of intervention vs control conditions
All included trials (58–63,71–75)† 1.01 (0.48 to 1.54) <.001
Included trials (58–62,71–75)‡; outlier trial (63) removed§ 0.43 (0.30 to 0.56) <.001
Included trials (58–62,71–75) using lowest reported effect size 0.36 (0.22 to 0.49) <.001
Included trials (58–62,71–75) using highest reported effect size 0.50 (0.31 to 0.70) <.001
Effect of intervention compared with control conditions postintervention and at follow-up assessments
Included trials with 6–8 mos postrandomization follow-up assessments (59,72,74)
Postintervention 0.54 (0.27 to 0.82) <.001
Follow-up 0.56 (0.34 to 0.78) <.001
Included trials with 12–18 mos postrandomization follow-up assessments (73–75)
Postintervention 0.34 (0.16 to 0.53) <.001
Follow-up 0.37 (0.18 to 0.55) <.001
Included trial with 24 mos postrandomization follow-up assessments (75)
Postintervention 0.26 (0.02 to 0.51) .040
Follow-up 0.19 (-0.08 to 0.46) .173
Subgroup analyses
Effect of CBT vs PST vs pharmacologic interventions
CBT(59,61) 0.83 (0.48 to 1.18) <.001
PST (72–75) 0.33 (0.15 to 0.50) <.001
Pharmacologic (58,60,62,71) 0.44 (0.19 to 0.68) <.001
Effect of intervention in psychotherapeutic trials meeting PEDro criterion: Whether at least 85% of study participants had postintervention data available for analysis
Criterion met (59,74) 0.58 (0.34 to 0.81) <.001
Criterion not met (61,72,73) 0.31 (0.10 to 0.52) .004

* Hedges’ g was calculated on the basis of the standardized mean difference effect size which uses the pooled within-groups SD. Subgroup analyses used a mixed effects model, which pools studies within subgroups with a random effects model, but tested for statistically significant between-groups differences with a fixed effects model. All P values are two-tailed. CBT = cognitive behavioral therapy; PST = problem-solving therapy.

† Heterogeneity: I 2 = 93.4%, 95% CI = 90.0 to 95.0; Q = 181.1, degrees of freedom (df) = 12, P < .001.

‡ Heterogeneity: I 2 = 0%, 95% CI = 0.0 to 60.0; Q = 8.67, df = 10, P = .56.

§ Comparisons from Nezu et al. (63) included examination of effects of PST (Hedges’ g = 3.57, 95% CI = 2.90 to 4.23, P < .001) and PST with involvement of a significant other (Hedges’ g = 4.32, 95% CI = 3.55 to 5.08, P < .001).